CRO

Sygnature Discovery Unveils £1 Million Chemistry Facility Upgrade

Sygnature Discovery, an integrated drug discovery CRO, has completed a major enhancement to its high-throughput chemistry (HTC) capabilities and laboratory infrastructure following a £1 million investment.

The Pharma CDMO Challenge

CatSci Appoints two Business Development Managers

CatSci Appoints Paul Bradley as Head of Business Development

Lynn Lewis Appointed as SVP of Global Sales at Envigo

Concept Buys CRO Aquila BioMedical

The Winning Formula

The Winning Formula

Accelerating the Benefits Achievable from Biocatalysis

PCRAMS is a Booming Business

Outsourcing Biopharmaceutical Manufacturing

Codexis Sees Success in Pharma Business...

Hovione Appoints Mike Ironside as General Manager TTC

Clinilabs Opens Phase I Unit in New Jersey

Pharma Must Make Big Changes to Survive

Pharma’s Future with a Disaggregated Supply Chain